Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Muscles can make their own androgens, which may help muscle growth.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Mutations in certain receptors can cause diseases and offer new treatment options.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.